MALLINCKRODT
Their evolution as a company starts now, and they are poised for an exciting future. Their core strengths provide the impetus for future success, including skills in the acquisition and management of highly regulated raw materials; strong regulatory knowledge, reputation, and relationships; distinctive manufacturing and logistics skills where vertical integration is an advantage; expertise in specialized chemistry, development, and formulation; and global commercial reach.
MALLINCKRODT
Social Links:
Industry:
Biotechnology
Founded:
1867-01-01
Address:
Blanchardstown, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.mallinckrodt.com
Total Employee:
5001+
Status:
Active
Contact:
+1 314-654-2000
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-12-26 | Sucampo Pharmaceuticals | Sucampo Pharmaceuticals acquired by Mallinckrodt | 1.2 B USD |
| 2017-11-02 | Ocera Therapeutics | Ocera Therapeutics acquired by Mallinckrodt | 42 M USD |
| 2017-08-04 | InfaCare Pharmaceutical | InfaCare Pharmaceutical acquired by Mallinckrodt | N/A |
| 2016-08-10 | Stratatech Corporation | Stratatech Corporation acquired by Mallinckrodt | N/A |
| 2015-08-10 | Therakos | Therakos acquired by Mallinckrodt | 1.33 B USD |
| 2015-03-05 | Ikaria | Ikaria acquired by Mallinckrodt | 2.3 B USD |
| 2014-04-07 | Questcor Pharmaceuticals | Questcor Pharmaceuticals acquired by Mallinckrodt | N/A |
| 2014-02-11 | Cadence Pharmaceuticals | Cadence Pharmaceuticals acquired by Mallinckrodt | N/A |
| 2012-09-24 | CNS Therapeutics (Old) | CNS Therapeutics (Old) acquired by Mallinckrodt | 100 M USD |
| 1997-07-24 | Nellcor Puritan Bennett | Nellcor Puritan Bennett acquired by Mallinckrodt | 1.81 B USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-07-18 | Silence Therapeutics | Mallinckrodt investment in Post-IPO Equity - Silence Therapeutics | 5 M USD |
Newest Events participated
Participated in American Association of Nurse Anesthetists (AANA) 2017 Annual Congress
on 2017-09-08 as exhibitor
Official Site Inspections
http://www.mallinckrodt.com Semrush global rank: 1.88 M Semrush visits lastest month: 11.69 K
- Host name: 45.60.240.79
- IP address: 45.60.240.79
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Mallinckrodt"
Corporate Culture | Mallinckrodt Pharmaceuticals
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, (in examination under Part 10 of the Companies Act 2014), which is registered in Ireland as a public limited …See details»
Leadership Team | Mallinckrodt Pharmaceuticals
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, (in examination under Part 10 of the Companies Act 2014), which is registered in Ireland as a public limited …See details»
Mallinckrodt - Wikipedia
Mallinckrodt Pharmaceuticals plc is an American-Irish domiciled manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents. In 2017, it generated 90% of its sales from the U.S. healthcare system. While Mallinckrodt is headquartered in Ireland for tax purposes, its operational headquarters are in the U.S. Mallinckrodt's 2013 tax inversionSee details»
Our Story | Mallinckrodt Pharmaceuticals
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, (in examination under Part 10 of the Companies Act 2014), which is registered in Ireland as a public limited …See details»
Our Values & Culture | Careers | Mallinckrodt Pharmaceuticals
At Mallinckrodt, we believe that our strength lies in our differences. We know that better outcomes for patients come from innovative thinking powered by a diverse and inclusive culture. …See details»
Mallinckrodt - Crunchbase Company Profile & Funding
Mallinckrodt reported positive financial results for the second and third quarters of 2024, leading to an increase in their full-year financial guidance. Learn more. Find More Contacts for …See details»
158 Years | Mallinckrodt Pharmaceuticals
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, (in examination under Part 10 of the Companies Act 2014), which is registered in Ireland as a public limited …See details»
Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical …
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, (in examination under Part 10 of the Companies Act 2014), which is registered in Ireland as a public limited …See details»
Mallinckrodt - Org chart - The Org
Explore Mallinckrodt's organizational chart. Discover current team members including executives, board members, and advisors. ... Get your company on The Org for free, joining over 140,000 …See details»
Mallinckrodt and Endo to Combine to Create a Global, Scaled ...
Mar 13, 2025 Mallinckrodt will continue as the holding company for the combined business, and Endo will become a wholly-owned subsidiary of Mallinckrodt. Mallinckrodt's existing senior …See details»
Mallinckrodt - Leadership Team - The Org
The Leadership Team at Mallinckrodt drives the strategic direction and operational excellence of the company, ensuring the development and delivery of innovative treatments across …See details»
Mallinckrodt's Leadership Team - Team members and org chart
Mallinckrodt's Leadership Team includes Bryan Reasons and 6 others. Team members. Bryan Reasons. Executive Vice President and C... Henriette Nielsen. EVP & Chief Transformation …See details»
Mallinckrodt Builds Leadership To Support Continued Growth
DUBLIN, Jan. 7, 2015 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, announced today that it will enhance commercial capabilities to …See details»
Corporate Governance | Mallinckrodt Pharmaceuticals
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, (in examination under Part 10 of the Companies Act 2014), which is registered in Ireland as a public limited …See details»
Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2024 …
Mar 13, 2025 The "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Mallinckrodt's Annual Report on Form 10-K …See details»
Get to Know Our Specialty Pharmaceutical Company | Mallinckrodt ...
Mallinckrodt’s growing portfolio of specialty pharmaceuticals helps treat a wide variety of health conditions. Mallinckrodt’s work reflects its strategic vision to be an innovation-driven specialty …See details»
Mallinckrodt - Contacts, Employees, Board Members, Advisors
Mallinckrodt has 2 board members and advisors, including David Carlucci. Contacts. Edit Contacts Section. Job Department. Protected Content. Associate General Counsel - Business …See details»
Drugmakers Mallinckrodt and Endo Are in Talks to Merge - BNN …
Mar 12, 2025 (Bloomberg) -- Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people with knowledge of the matter …See details»
Mallinckrodt and Endo plan merger as they look to recover from …
Mar 13, 2025 Mallinckrodt Pharmaceuticals plc and Endo Inc. said Thursday they are combining as part of a stock-and-cash deal with an enterprise value of $6.7 billion that will give both …See details»
Mallinckrodt's CEO and Executive Team - The Org
About. Mallinckrodt's CEO and Executive Team includes Hugh O’Neill and 6 others.See details»